These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2251110)

  • 1. [Scientific theory and drug abuse research].
    Jepsen PW
    Nord Med; 1990; 105(11):310-3. PubMed ID: 2251110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
    Greig RL; Baker A; Lewin TJ; Webster RA; Carr VJ
    Drug Alcohol Rev; 2006 May; 25(3):249-58. PubMed ID: 16753649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personality disorders and substance abuse disorders. Psychosocial strategies].
    Lana Moliner F
    Actas Esp Psiquiatr; 2001; 29(1):58-66. PubMed ID: 11333520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Foundations of the new phylogenetics].
    Pavlinov IIa
    Zh Obshch Biol; 2004; 65(4):334-66. PubMed ID: 15490579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes.
    Ouimette PC; Gima K; Moos RH; Finney JW
    Alcohol Clin Exp Res; 1999 Mar; 23(3):552-7. PubMed ID: 10195832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.
    Goodman AC; Hankin JR; Kalist DE; Peng Y; Spurr SJ
    J Ment Health Policy Econ; 2001 Jun; 4(2):65-77. PubMed ID: 11967467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
    Pezard L; Nandrino JL
    Encephale; 2001; 27(3):260-8. PubMed ID: 11488256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model.
    Leventhal AM; Schmitz JM
    Addict Behav; 2006 Nov; 31(11):2038-62. PubMed ID: 16616433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and prevention in adolescent substance abuse: a biopsychosocial approach.
    Briones DF; Wilcox JA; Mateus B; Boudjenah D
    Adolesc Med Clin; 2006 Jun; 17(2):335-52. PubMed ID: 16814697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of child abuse and neglect on the later appearance of substance abuse].
    Holovits Z; Gerevich J; Pálinkás BA
    Psychiatr Hung; 2009; 24(3):185-92. PubMed ID: 19794226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.